Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus
- PMID: 6186823
- PMCID: PMC255125
- DOI: 10.1128/JVI.46.1.311-316.1983
Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus
Abstract
Iodination of intact foot-and-mouth disease virus results in the selective labeling of VP1, substantiating its exposed location on the virion. A comparison of tryptic peptides revealed that a single tyrosine-containing peptide was labeled with iodine on intact or protease-cleaved virus. The labeled peptide from intact and protease-cleaved virus was characterized by molecular weight sizing and sequence analysis. Carboxypeptidase digestion of intact VP1, limited trypsin-cleaved VP1, and VP1 purified from bacterially contaminated tissue cultures yielded carboxyterminal residues of leucine, valine-arginine, and serine-alanine, respectively. The correlation of these findings with previous data on the amino acid sequence derived from nucleotide sequencing of serotypes A12 and O1 of foot-and-mouth disease virus VP1 places the probable exposed antigenic region of VP1 in a serotype-variable region including residues 136 through 144.
Similar articles
-
Foot-and-mouth disease and its antigens.Adv Exp Med Biol. 1985;185:27-46. doi: 10.1007/978-1-4684-7974-4_2. Adv Exp Med Biol. 1985. PMID: 2416203 Review.
-
Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus.J Gen Virol. 1983 Nov;64 (Pt 11):2357-65. doi: 10.1099/0022-1317-64-11-2357. J Gen Virol. 1983. PMID: 6196439
-
Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.Virus Res. 1984 Sep;1(6):489-500. doi: 10.1016/0168-1702(84)90006-6. Virus Res. 1984. PMID: 6085200
-
Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP.Vet Microbiol. 1982 May;7(2):85-96. doi: 10.1016/0378-1135(82)90020-7. Vet Microbiol. 1982. PMID: 6287701
-
Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.J Biotechnol. 1996 Jan 26;44(1-3):83-9. doi: 10.1016/0168-1656(95)00090-9. J Biotechnol. 1996. PMID: 8717390 Review.
Cited by
-
Pathological and genetic characterization of foot and mouth disease viruses collected from cattle and water buffalo in Egypt.PLoS One. 2023 Oct 11;18(10):e0291970. doi: 10.1371/journal.pone.0291970. eCollection 2023. PLoS One. 2023. PMID: 37819946 Free PMC article.
-
The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells.Virus Genes. 1990 Jun;4(1):73-83. doi: 10.1007/BF00308567. Virus Genes. 1990. PMID: 2168107
-
Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds.Clin Vaccine Immunol. 2007 Dec;14(12):1634-9. doi: 10.1128/CVI.00339-07. Epub 2007 Oct 17. Clin Vaccine Immunol. 2007. PMID: 17942610 Free PMC article.
-
Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.J Virol. 2003 Feb;77(4):2500-11. doi: 10.1128/jvi.77.4.2500-2511.2003. J Virol. 2003. PMID: 12551988 Free PMC article.
-
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12.J Virol. 1985 Jun;54(3):651-60. doi: 10.1128/JVI.54.3.651-660.1985. J Virol. 1985. PMID: 2987518 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources